BIOMAT Database Logo BIOMAT Database Logo

An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts. 1971

E Mayhew, and M Bennett

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D011830 Radiation Effects The effects of ionizing and nonionizing radiation upon living organisms, organs and tissues, and their constituents, and upon physiologic processes. It includes the effect of irradiation on food, drugs, and chemicals. Effects, Radiation,Effect, Radiation,Radiation Effect
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

E Mayhew, and M Bennett
An immunofluorescence study of the in vitro interaction between lymphoid cells and target cells.
November 1969, Journal of immunology (Baltimore, Md. : 1950),
E Mayhew, and M Bennett
Rejection of ascites tumor allografts. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cells.
December 1972, The Journal of experimental medicine,
E Mayhew, and M Bennett
THE REACTION OF IMMUNOLOGICALLY ACTIVATED LYMPHOID CELLS AGAINST HOMOLOGOUS LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET TISSUE CELLS IN VITRO.
December 1963, Journal of cellular and comparative physiology,
E Mayhew, and M Bennett
Production of complement by spleen cells in vitro and its possible role in an allograft rejection model.
November 1968, Nature,
E Mayhew, and M Bennett
An in vitro model for tumor progression in murine lymphoid cells.
January 1986, Current topics in microbiology and immunology,
E Mayhew, and M Bennett
Is lymphoid neogenesis a therapeutic target for chronic rejection?
May 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
E Mayhew, and M Bennett
Ultrastructural study of the relationship between immune cytotoxic lymphoid cells and target cells in vitro.
January 1975, Virchows Archiv. B, Cell pathology,
E Mayhew, and M Bennett
Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection.
March 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
E Mayhew, and M Bennett
Symposium: Blood culture and its biological significance. Reaction of the lymphoid cells on target cells in vitro.
October 1968, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
E Mayhew, and M Bennett
Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
December 2010, Transplantation,
Copied contents to your clipboard!